Explore more publications!
Healthy Living South Dakota
Got News to Share?

Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 5, 2025

Biomea Fusion Showcases Preclinical Advances for BMF-650 and Icovamenib with Low Dose Semaglutide at ObesityWeek® 2025
November 5, 2025

Biomea Fusion Showcases Preclinical Advances for BMF-650 and Icovamenib with Low Dose Semaglutide at ObesityWeek® 2025

Indeterminate GlobeNewswire
Sionna Therapeutics Reports Third Quarter 2025 Financial Results
November 5, 2025

Sionna Therapeutics Reports Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
Foghorn Therapeutics Provides Third Quarter 2025 Financial and Corporate Update
November 5, 2025

Foghorn Therapeutics Provides Third Quarter 2025 Financial and Corporate Update

Indeterminate GlobeNewswire
BioCryst to Present at Upcoming Investor Conference
November 5, 2025

BioCryst to Present at Upcoming Investor Conference

Indeterminate GlobeNewswire
Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights
November 5, 2025

Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights

Indeterminate GlobeNewswire
BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters
November 5, 2025

BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters

Indeterminate GlobeNewswire
Jaya Biosciences Receives U.S. Patent for Novel Methods of Treating Neurological Diseases, Including Alzheimer’s Disease, Expanding its Global Intellectual Property Portfolio
November 5, 2025

Jaya Biosciences Receives U.S. Patent for Novel Methods of Treating Neurological Diseases, Including Alzheimer’s Disease, Expanding its Global Intellectual Property Portfolio

Indeterminate GlobeNewswire
Arvinas Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 5, 2025

Arvinas Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Seres Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
November 5, 2025

Seres Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire
Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast® Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study
November 5, 2025

Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast® Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study

Indeterminate GlobeNewswire
Microbix Addresses Cybersecurity Incident
November 5, 2025

Microbix Addresses Cybersecurity Incident

Indeterminate GlobeNewswire
Upstream Bio Reports Third Quarter 2025 Financial Results and Highlights Continued Progress
November 5, 2025

Upstream Bio Reports Third Quarter 2025 Financial Results and Highlights Continued Progress

Indeterminate GlobeNewswire
Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program
November 5, 2025

Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program

Indeterminate GlobeNewswire
Skye Bioscience to Announce Third Quarter 2025 Financial Results and Business Update on November 10, 2025
November 5, 2025

Skye Bioscience to Announce Third Quarter 2025 Financial Results and Business Update on November 10, 2025

Indeterminate GlobeNewswire
Eledon Pharmaceuticals to Present at Guggenheim Second Annual Healthcare Innovation Conference
November 5, 2025

Eledon Pharmaceuticals to Present at Guggenheim Second Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire
atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies
November 5, 2025

atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies

Indeterminate GlobeNewswire
Clearmind Expands Global IP Protection for MEAI in Depression Treatment with New South Korea Patent Filing
November 5, 2025

Clearmind Expands Global IP Protection for MEAI in Depression Treatment with New South Korea Patent Filing

Indeterminate GlobeNewswire
Fortrea Reports Third Quarter 2025 Results
November 5, 2025

Fortrea Reports Third Quarter 2025 Results

Indeterminate GlobeNewswire
Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
November 5, 2025

Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Ocugen Provides Business Update with Third Quarter 2025 Financial Results
November 5, 2025

Ocugen Provides Business Update with Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions